Characterization of Patients at High Risk for the Acquisition of Sexually Transmitted Infection With the Human Immunodeficiency Virus (HIV) - a Clinical Study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- HIV Infections
- Sponsor
- Medical University of Vienna
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Incidence of HIV
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
The main objective of this prospective observational cohort study is to investigate the epidemiology, the risk factors and ultimately the incidence of novel HIV infections among individuals at high risk for acquiring HIV via sex practices.
Detailed Description
We will include individuals at high-risk for HIV acquisition, i.e. HIV-negative MSM and transgender individuals who (i) do not use condoms consistently with casual partners and/or with HIV-positive partners who are not on treatment and/or (ii) recently acquired an STI and/or (iii) recently used PEP and/or (iv) frequently engage in 'chemsex' within the past 12 months Important clinical information on possible vectors for transmission (including but not limited to high-risk sex practices and sexualized drug use), use of HIV pre-exposure prophylaxis, incidence of sexually transmitted infections will be assessed and laboratory parameters will be obtained from blood, urine and mucosal secretion.
Investigators
Armin Rieger, MD
Ass.-Prof. Dr.med.univ.
Medical University of Vienna
Eligibility Criteria
Inclusion Criteria
- •High risk for acquiring HIV defined as followed: HIV-negative MSM and transgender individuals who (i) do not use condoms consistently with casual partners and/or with HIV-positive partners who are not on treatment and/or (ii) recently acquired an STI and/or (iii) recently used PEP and/or (iv) frequently engage in 'chemsex'.
- •Age \>18 years and \<100 years.
- •Written informed consent for this registry study.
Exclusion Criteria
- •Withdrawal of the written informed consent.
Outcomes
Primary Outcomes
Incidence of HIV
Time Frame: Up to 10 years (=Study Period)
Time from inclusion to HIV infection
Secondary Outcomes
- Incidence of sexually transmitted infections(Up to 10 years (=Study Period))